Adding Antithrombotic to tPA Does Not Improve Stroke Outcome

Argatroban and eptifibatide were ineffective as adjunctive therapies to thrombolysis in patients with ischemic stroke in the MOST trial.

Related Keywords

University Of Texas , Texas , United States , Houston , Missouri , Phoenix , Arizona , Washington University , Opeolum Adeoye , Larryb Goldstein , Andrewd Barreto , , Department Of Neurology , International Stroke Conference , University Of Texas Health Science Center , Washington University School Of Medicine , National Institutes Of Health Stroke Scale , University Of Kentucky , Washington University School , Medscape Medical , Multi Arm Optimization , Stroke Thrombolysis , Texas Health Science Center , National Institutes , Health Stroke Scale , Rankin Scale , Stroke Cerebrovascular Accident Cva , Thromboembolism , Antithrombotics , Anti Thrombotics , Antithrombotic Therapy , Antithrombotic Agents , Ischemic Stroke Ischaemic , Thrombolytic Therapy , Fibrinolytics , Thrombolytics , Blood , Endovascular Techniques , Endovascular Surgery , Endovascular Therapy , Endovascular Repair , Blood Vessels , Intracranial Hemorrhage ,